IBT Share Price

Open 0.16 Change Price %
High 0.16 1 Day 0.00 0.00
Low 0.16 1 Week 0.00 0.00
Close 0.16 1 Month 0.04 33.33
Volume 5200 1 Year 0.05 45.45
52 Week High 0.18
52 Week Low 0.08
IBT Important Levels
Resistance 2 0.16
Resistance 1 0.16
Pivot 0.16
Support 1 0.16
Support 2 0.16
CVE Canada Most Active Stocks
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
More..
CVE Canada Top Gainers Stocks
MCG 0.02 100.00%
AZU 0.02 100.00%
AZU 0.02 100.00%
BVQ 0.02 100.00%
ZMD 0.02 100.00%
DDX 0.50 100.00%
PTR 0.02 100.00%
PTR 0.02 100.00%
PTR 0.02 100.00%
SVT 0.04 100.00%
More..
CVE Canada Top Losers Stocks
FEM 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
IXI 0.02 -50.00%
KLM 0.01 -50.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
More..

Ibex Technologies (CVE: IBT)

IBT Technical Analysis 5
As on 22nd Feb 2017 IBT Share Price closed @ 0.16 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.12 & Strong Buy for SHORT-TERM with Stoploss of 0.11 we also expect STOCK to react on Following IMPORTANT LEVELS.
IBT Target for February
1st Target up-side 0.12
2nd Target up-side 0.13
3rd Target up-side 0.14
1st Target down-side 0.1
2nd Target down-side 0.09
3rd Target down-side 0.08
IBT Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.ibex.ca
IBT Address
IBT
5485 Pare Street
Suite 100
Montreal, QC H4P 1P7
Canada
Phone: 514-344-4004
Fax: 514-344-8827
IBT Latest News
Mid-Day Market Update: Community Health Systems Gains On Earnings Beat ...   Nasdaq   - 22nd Feb 17
Mid-Morning Market Update: Markets Mostly Higher; Wendys Posts Mixed Q4 Report   Benzinga   - 16th Feb 17
IBEX closes early as Hurricane Matthew heads for Florida   Trade Only Today   - 06th Oct 16
IBEX 2016: Speakers address technology's effect on industry   Trade Only Today   - 06th Oct 16
METS and IBEX Join Forces   Scuttlebutt Sailing News   - 04th Oct 16
Serum Cartilage Biomarkers and Shoulder Instability   Healio   - 02nd Oct 16
Audacious Stem Cell Plan Aims to Halt Rhino Extinction   Scientific American   - 03rd May 16
Ibex Global Hires Industry Veteran as CIO   Wall Street Journal (blog)   - 08th Jan 16
Meet the Time-Traveling Scientist Behind Editas, the Biotech Company Going ...   Re/code   - 05th Jan 16
IBEX Reports Results for the Year Ended July 31, 2014   Marketwired (press release)   - 29th Oct 14
Interactive Technical Analysis Chart Ibex Technologies ( IBT CVE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Ibex Technologies
IBT Business Profile
IBEX Technologies Inc., a biopharmaceutical company, engages in the production and sale of proprietary enzymes for use as reagents in hemostasis monitoring devices. The company also provides arthritis diagnostic kits, including Collagen Type II Cleavage Assay that measures real-time collagen type II degradation; Collagen Type I and II Cleavage Assay, which measures the amount of real-time collagen of types I and II degradation; CPII Assay-Cartilage that monitors changes in the rate of synthesis of cartilage components of type II collagen indicative of osteoarthritis and rheumatoid arthritis; and Aggrecan Chondroitin Sulfate 846 Epitope Assay, which monitors changes in the rate of synthesis of cartilage components of aggrecan indicating osteoarthritis and rheumatoid arthritis. IBEX offers its arthritis diagnostic kits primarily for the pharmaceutical research. In addition, the company provides cartilage biomarker antibodies comprising Ab1320 Aggrecan NITEGE rabbit, Col M, Type IX Collagen, and C1-2C. Further, it offers heparinase II and heparinase III research reagents; chondroitinase AC that acts as a research reagent, and involved in degradation of hyaluronic acid; and chondroitinase B, a research reagent. Additionally, the company provides sample testing services. It sells its products primarily in Canada, the United States, and Europe. The company is based in Montreal, Canada.